Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-003563
Accepted
2024-11-25 00:15:13
Documents
1
Effectiveness Date
2024-11-22
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 597
  Complete submission text file 9999999995-24-003563.txt   1763
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-283226 | Film No.: 241491751
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)